Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 70% ± 24% | |
peripheral blood | 21 studies | 81% ± 19% | |
brain | 18 studies | 40% ± 18% | |
intestine | 13 studies | 71% ± 23% | |
eye | 10 studies | 66% ± 24% | |
kidney | 9 studies | 74% ± 19% | |
liver | 8 studies | 56% ± 23% | |
bone marrow | 7 studies | 47% ± 24% | |
heart | 7 studies | 28% ± 14% | |
lymph node | 6 studies | 78% ± 23% | |
pancreas | 5 studies | 77% ± 26% | |
placenta | 5 studies | 72% ± 30% | |
uterus | 5 studies | 89% ± 14% | |
prostate | 5 studies | 71% ± 24% | |
breast | 5 studies | 75% ± 30% | |
adipose | 4 studies | 58% ± 28% | |
esophagus | 4 studies | 62% ± 29% | |
skin | 4 studies | 57% ± 32% | |
stomach | 4 studies | 46% ± 22% | |
adrenal gland | 3 studies | 80% ± 17% | |
thymus | 3 studies | 76% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 34074.59 | 170 / 170 | 100% | 600.74 | 459 / 459 |
skin | 100% | 37973.08 | 1808 / 1809 | 100% | 557.72 | 472 / 472 |
esophagus | 100% | 41276.68 | 1444 / 1445 | 100% | 469.16 | 183 / 183 |
lung | 100% | 51604.31 | 578 / 578 | 100% | 542.06 | 1154 / 1155 |
kidney | 100% | 30522.57 | 89 / 89 | 100% | 700.62 | 900 / 901 |
prostate | 100% | 28825.57 | 245 / 245 | 100% | 487.00 | 501 / 502 |
breast | 100% | 45541.60 | 459 / 459 | 100% | 671.70 | 1113 / 1118 |
thymus | 100% | 31443.68 | 650 / 653 | 100% | 514.17 | 605 / 605 |
intestine | 100% | 34526.04 | 966 / 966 | 99% | 468.71 | 524 / 527 |
bladder | 100% | 46066.81 | 21 / 21 | 99% | 553.07 | 499 / 504 |
ovary | 99% | 21835.92 | 178 / 180 | 100% | 368.10 | 430 / 430 |
adrenal gland | 100% | 26805.21 | 258 / 258 | 98% | 561.22 | 226 / 230 |
stomach | 98% | 29217.10 | 353 / 359 | 100% | 405.95 | 285 / 286 |
brain | 98% | 25746.91 | 2582 / 2642 | 100% | 632.44 | 705 / 705 |
pancreas | 88% | 11535.57 | 287 / 328 | 100% | 630.26 | 178 / 178 |
liver | 85% | 16062.09 | 192 / 226 | 100% | 373.02 | 406 / 406 |
adipose | 100% | 52874.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 447.37 | 29 / 29 |
muscle | 100% | 93736.49 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 21810.40 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 615.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 302.63 | 1 / 1 |
blood vessel | 100% | 55463.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 55039.12 | 924 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 315.70 | 79 / 80 |
heart | 96% | 33048.08 | 825 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019941 | Biological process | modification-dependent protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0010008 | Cellular component | endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031982 | Cellular component | vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0031386 | Molecular function | protein tag activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | UBC |
Protein name | UBC protein UBC protein (Ubiquitin C) Polyubiquitin-C [Cleaved into: Ubiquitin] Ubiquitin C Ubiquitin C splice variant |
Synonyms | UbC hCG_1744180 |
Description | FUNCTION: [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in proteotoxic stress response and cell cycle; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. . |
Accessions | F5H265 F5H6Q2 ENST00000535859.1 F5H388 Q96C32 A8CGI2 ENST00000339647.6 ENST00000546271.1 ENST00000542416.1 Q5UGI3 F5GXK7 ENST00000536769.1 F5H747 ENST00000538617.5 ENST00000540351.1 L8B4I8 ENST00000541272.1 ENST00000540700.1 F5H2Z3 P0CG48 ENST00000535131.1 F5GZ39 Q96H31 F5GYU3 ENST00000541645.1 Q5PY61 |